Now, amyloid and p-tau are both considered equally critical with an amyloid-first or a p-tau-first emergence of AD pathology (Small and Duff, 2008; Paul de Paula et al., 2009; Chételat, 2013). The gene discussed is MAPT; the disease is Alzheimer disease.